Ligand validation:3CAV

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CAV_EDO_A_332	60%	37%	0.12	0.906	2.26	0.32	1	-	0	0	100%	1
3CAV_EDO_B_330	55%	35%	0.127	0.894	2.32	0.35	1	-	0	0	100%	1
3CAV_EDO_A_330	54%	34%	0.177	0.944	2.4	0.37	1	-	2	0	100%	1
3CAV_EDO_A_331	45%	36%	0.161	0.894	2.31	0.32	1	-	1	0	100%	1
3CAV_EDO_B_331	26%	36%	0.267	0.911	2.31	0.34	1	-	0	0	100%	1
3CAS_EDO_A_330	48%	38%	0.14	0.884	2.27	0.29	1	-	1	0	100%	1
3CAQ_EDO_A_329	43%	38%	0.102	0.824	2.27	0.27	1	-	1	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.